Sanofi Contingent Value Right (Expiring 12/31/2020) (GCVRZ)
$0.8711 0 (
+0%)
Volume:
Date: 8:42 EDT
Sanofi Contingent Value Right (Expiring 12/31/2020) Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sanofi Contingent Value Right (Expiring 12/31/2020) Key Statistics
Name | Value | ||
---|---|---|---|
Day's Open ($) | 0.8711 | ||
Day's Range ($) | 0.8711 - 0.8711 | ||
Day's Volume | |||
52-Week Range ($) | 0.43 - 0.882 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility | - | ||
14-Day RSI | - | ||
14-Day ATR ($) | - | ||
20-Day SMA ($) | - |
Fundamental Data
Name | Value | ||
---|---|---|---|
Market Cap (Mil $) | - | ||
Shares Outstanding (Mil) | - | ||
PE Ratio | - | ||
PE Ratio (10y Range) | - | ||
PE Ratio (10y Median) | - | ||
PB Ratio | - | ||
PB Ratio (10y Range) | - | ||
PB Ratio (10y Median) | - |
Dividend Data
Name | Value | ||
---|---|---|---|
Dividends per Share (TTM) ($) | - | ||
Dividend Yield % | - | ||
Dividend Yield % (10y Range) | - | ||
Dividend Yield % (10y Median) | - | ||
Next Dividend Payment Date | |||
Dividend Frequency | - |
GCVRZ Sanofi Contingent Value Right (Expiring 12/31/2020) Fundamental Charts
Historical TTM Price-to-Earnings for GCVRZ Sanofi Contingent Value Right (Expiring 12/31/2020)
Historical TTM Price-to-Earnings without NRI for GCVRZ Sanofi Contingent Value Right (Expiring 12/31/2020)
Historical Price-to-Book Ratio for GCVRZ Sanofi Contingent Value Right (Expiring 12/31/2020)
Historical Dividend Yields for GCVRZ Sanofi Contingent Value Right (Expiring 12/31/2020)
Sanofi Contingent Value Right (Expiring 12/31/2020) Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with NAS:GCVRZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:GCVRZ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Discussions on Sanofi Contingent Value Right (Expiring 12/31/2020)
No discussions yet.